For example, clinical resolution of human asthma could not be demonstrated by targeting eosinophils with anti-IL-5 therapy [3], despite the many studies in animal models that have shown the success of IL-5 neutralization in blocking experimental asthma [4-6]. This evidence concerns the gene IL5 and asthma.